Skip to content
Clinical Development

Medpace Recognizes World Obesity Day

  • March 4, 2024

Cutting-Edge Trial Design & Execution in Obesity

March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the obesity crisis. Medpace recognizes the urgent need to address this global health crisis and we’re committed to combating obesity through cutting-edge clinical trial design and execution.

With decades of phase I-IV metabolic experience, Medpace is the leading global CRO for obesity clinical studies. Our seasoned medicaloperational, and regulatory teams are embedded throughout your project and remain laser-focused on execution – providing unparalleled support for your trial.  Extensive team experience, strong relationships with trial sites and key investigators augmented by advanced in-house and external data streams (Intellipace®) enable Medpace to effectively support the planning and successful delivery of rare to multi-trial mega programs.

In commemoration of World Obesity Day, we invite you to hear more from our global team of medical and operational obesity experts.

Learn more about Medpace’s experience in: